These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


314 related items for PubMed ID: 15625305

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C, Rahmani M, Dai Y, Conrad D, Krystal G, Dent P, Grant S.
    Cancer Res; 2003 Apr 15; 63(8):1822-33. PubMed ID: 12702569
    [Abstract] [Full Text] [Related]

  • 23. Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway.
    Hundal RS, Salh BS, Schrader JW, Gómez-Muñoz A, Duronio V, Steinbrecher UP.
    J Lipid Res; 2001 Sep 15; 42(9):1483-91. PubMed ID: 11518769
    [Abstract] [Full Text] [Related]

  • 24. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction.
    Negoro S, Oh H, Tone E, Kunisada K, Fujio Y, Walsh K, Kishimoto T, Yamauchi-Takihara K.
    Circulation; 2001 Jan 30; 103(4):555-61. PubMed ID: 11157722
    [Abstract] [Full Text] [Related]

  • 25. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells.
    Jin YP, Fishbein MC, Said JW, Jindra PT, Rajalingam R, Rozengurt E, Reed EF.
    Hum Immunol; 2004 Apr 30; 65(4):291-302. PubMed ID: 15120184
    [Abstract] [Full Text] [Related]

  • 26. Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I.
    Kulik G, Weber MJ.
    Mol Cell Biol; 1998 Nov 30; 18(11):6711-8. PubMed ID: 9774684
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Chemotactic peptide-induced activation of MEK-2, the predominant isoform in human neutrophils. Inhibition by wortmannin.
    Downey GP, Butler JR, Brumell J, Borregaard N, Kjeldsen L, Sue-A-Quan AK, Grinstein S.
    J Biol Chem; 1996 Aug 30; 271(35):21005-1011. PubMed ID: 8702863
    [Abstract] [Full Text] [Related]

  • 31. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM, Tazzari PL, Tabellini G, Bortul R, Billi AM, Manzoli L, Ruggeri A, Conte R, Cocco L.
    Leukemia; 2003 Sep 30; 17(9):1794-805. PubMed ID: 12970779
    [Abstract] [Full Text] [Related]

  • 32. Akt phosphorylates p47phox and mediates respiratory burst activity in human neutrophils.
    Chen Q, Powell DW, Rane MJ, Singh S, Butt W, Klein JB, McLeish KR.
    J Immunol; 2003 May 15; 170(10):5302-8. PubMed ID: 12734380
    [Abstract] [Full Text] [Related]

  • 33. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation.
    Liu H, Perlman H, Pagliari LJ, Pope RM.
    J Exp Med; 2001 Jul 16; 194(2):113-26. PubMed ID: 11457886
    [Abstract] [Full Text] [Related]

  • 34. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway.
    Birkenkamp KU, Geugien M, Schepers H, Westra J, Lemmink HH, Vellenga E.
    Leukemia; 2004 Jan 16; 18(1):103-12. PubMed ID: 14574326
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
    Hayakawa J, Ohmichi M, Kurachi H, Kanda Y, Hisamoto K, Nishio Y, Adachi K, Tasaka K, Kanzaki T, Murata Y.
    Cancer Res; 2000 Nov 01; 60(21):5988-94. PubMed ID: 11085518
    [Abstract] [Full Text] [Related]

  • 36. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms.
    Liu Y.
    Am J Physiol; 1999 Oct 01; 277(4):F624-33. PubMed ID: 10516287
    [Abstract] [Full Text] [Related]

  • 37. Regulation of phosphatidylinositol 3-kinase activity and phosphatidylinositol 3,4,5-trisphosphate accumulation by neutrophil priming agents.
    Cadwallader KA, Condliffe AM, McGregor A, Walker TR, White JF, Stephens LR, Chilvers ER.
    J Immunol; 2002 Sep 15; 169(6):3336-44. PubMed ID: 12218155
    [Abstract] [Full Text] [Related]

  • 38. Bad as a converging signaling molecule between survival PI3-K/Akt and death JNK in neurons after transient focal cerebral ischemia in rats.
    Kamada H, Nito C, Endo H, Chan PH.
    J Cereb Blood Flow Metab; 2007 Mar 15; 27(3):521-33. PubMed ID: 16820799
    [Abstract] [Full Text] [Related]

  • 39. Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line.
    Eves EM, Xiong W, Bellacosa A, Kennedy SG, Tsichlis PN, Rosner MR, Hay N.
    Mol Cell Biol; 1998 Apr 15; 18(4):2143-52. PubMed ID: 9528786
    [Abstract] [Full Text] [Related]

  • 40. TNF-alpha induces protein synthesis through PI3-kinase-Akt/PKB pathway in cardiac myocytes.
    Hiraoka E, Kawashima S, Takahashi T, Rikitake Y, Kitamura T, Ogawa W, Yokoyama M.
    Am J Physiol Heart Circ Physiol; 2001 Apr 15; 280(4):H1861-8. PubMed ID: 11247802
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.